Xponance Inc. Grows Stock Holdings in Crocs, Inc. (NASDAQ:CROX)

Xponance Inc. grew its stake in shares of Crocs, Inc. (NASDAQ:CROXFree Report) by 5.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,372 shares of the textile maker’s stock after buying an additional 492 shares during the period. Xponance Inc.’s holdings in Crocs were worth $1,027,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CROX. Pacer Advisors Inc. raised its holdings in shares of Crocs by 39.6% in the 4th quarter. Pacer Advisors Inc. now owns 2,037,121 shares of the textile maker’s stock valued at $223,126,000 after acquiring an additional 577,467 shares in the last quarter. FMR LLC lifted its holdings in shares of Crocs by 4.8% in the 3rd quarter. FMR LLC now owns 8,907,591 shares of the textile maker’s stock worth $1,289,908,000 after acquiring an additional 406,287 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec purchased a new stake in Crocs during the third quarter valued at about $17,122,000. Motley Fool Wealth Management LLC bought a new position in Crocs during the 3rd quarter worth approximately $9,097,000. Finally, Fort Washington Investment Advisors Inc. OH grew its holdings in shares of Crocs by 34.0% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 184,670 shares of the textile maker’s stock worth $20,227,000 after purchasing an additional 46,890 shares during the last quarter. Institutional investors own 93.44% of the company’s stock.

Insider Transactions at Crocs

In other Crocs news, EVP Adam Michaels sold 15,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $106.69, for a total transaction of $1,600,350.00. Following the completion of the transaction, the executive vice president now owns 89,323 shares in the company, valued at $9,529,870.87. This trade represents a 14.38 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Shannon Sisler sold 4,659 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $109.75, for a total value of $511,325.25. Following the sale, the executive vice president now directly owns 29,299 shares in the company, valued at $3,215,565.25. This trade represents a 13.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.72% of the company’s stock.

Crocs Stock Down 0.8 %

NASDAQ CROX opened at $104.59 on Monday. The stock has a market cap of $5.86 billion, a PE ratio of 6.54, a P/E/G ratio of 1.80 and a beta of 1.84. The company has a current ratio of 1.18, a quick ratio of 0.70 and a debt-to-equity ratio of 0.74. Crocs, Inc. has a 12 month low of $88.25 and a 12 month high of $165.32. The stock’s 50 day moving average is $102.14 and its 200 day moving average is $113.48.

Crocs (NASDAQ:CROXGet Free Report) last posted its earnings results on Thursday, February 13th. The textile maker reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.25. Crocs had a net margin of 23.16% and a return on equity of 46.27%. Research analysts predict that Crocs, Inc. will post 13.2 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on CROX shares. Guggenheim reduced their price target on Crocs from $155.00 to $150.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Barclays lowered their price target on Crocs from $125.00 to $122.00 and set an “overweight” rating for the company in a research report on Friday, February 14th. Robert W. Baird decreased their price target on Crocs from $180.00 to $150.00 and set an “outperform” rating for the company in a research note on Monday, February 10th. UBS Group upped their price objective on Crocs from $122.00 to $132.00 and gave the company a “neutral” rating in a research report on Wednesday, February 19th. Finally, Bank of America raised their target price on Crocs from $144.00 to $153.00 and gave the stock a “buy” rating in a report on Friday, February 14th. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $143.53.

Get Our Latest Analysis on Crocs

Crocs Company Profile

(Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Read More

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.